These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 24289738)

  • 1. Evaluation of 6 years of confidential unit exclusion at the Belgian Red Cross Flanders Blood Service.
    Vandewalle G; Baeten M; Bogaerts K; Vandekerckhove P; Compernolle V
    Vox Sang; 2014 May; 106(4):354-60. PubMed ID: 24289738
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of the confidential unit exclusion on Iranian blood donors: An 11-year experience.
    Ameli MR; Hosseini SH; Rad F; Sajjadi SM
    Asian J Transfus Sci; 2021; 15(1):57-61. PubMed ID: 34349458
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Confidential unit exclusion (CUE): Double edged sword for blood transfusion center: A ten-year study on volunteer blood donors in Kohgiluyeh and Boyer Ahmad province, Iran.
    Rad F; Sajjadi SM; Azizi A; Maghsudlu M
    Transfus Clin Biol; 2019 Nov; 26(4):253-256. PubMed ID: 31174915
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Demographic characteristics and prevalence of serologic markers among blood donors who use confidential unit exclusion (CUE) in São Paulo, Brazil: implications for modification of CUE policies in Brazil.
    de Almeida-Neto C; Liu J; Wright DJ; Mendrone-Junior A; Takecian PL; Sun Y; Ferreira JE; de Alencar Fischer Chamone D; Busch MP; Sabino EC;
    Transfusion; 2011 Jan; 51(1):191-7. PubMed ID: 20663108
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of the confidential unit exclusion form: the Canadian Blood Services experience.
    O'Brien SF; Fan W; Xi G; Yi QL; Goldman M
    Vox Sang; 2010 Feb; 98(2):138-44. PubMed ID: 19754523
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence and causes of blood donor deferrals among clients presenting for blood donation in northern Tanzania.
    Valerian DM; Mauka WI; Kajeguka DC; Mgabo M; Juma A; Baliyima L; Sigalla GN
    PLoS One; 2018; 13(10):e0206487. PubMed ID: 30359434
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Demographic characteristics and prevalence of serologic markers among donors who use the confidential unit exclusion process: the Retrovirus Epidemiology Donor Study.
    Korelitz JJ; Williams AE; Busch MP; Zuck TF; Ownby HE; Matijas LJ; Wright DJ
    Transfusion; 1994 Oct; 34(10):870-6. PubMed ID: 7940658
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Current impact of the confidential unit exclusion option.
    Zou S; Notari EP; Musavi F; Dodd RY;
    Transfusion; 2004 May; 44(5):651-7. PubMed ID: 15104644
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Blood donor deferral pattern in Iran.
    Birjandi F; Gharehbaghian A; Delavari A; Rezaie N; Maghsudlu M
    Arch Iran Med; 2013 Nov; 16(11):657-60. PubMed ID: 24206408
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effectiveness of the confidential unit exclusion option.
    Petersen LR; Lackritz E; Lewis WF; Smith DS; Herrera G; Raimondi V; Aberle-Grasse J; Dodd RY
    Transfusion; 1994 Oct; 34(10):865-9. PubMed ID: 7940657
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk factors for prevalent and incident HIV infection in a cohort of volunteer blood donors in Harare, Zimbabwe: implications for blood safety.
    McFarland W; Mvere D; Katzenstein D
    AIDS; 1997 Sep; 11 Suppl 1():S97-102. PubMed ID: 9376107
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Understanding noncompliance with selective donor deferral criteria for high-risk behaviors in Australian blood donors.
    Lucky TT; Seed CR; Waller D; Lee JF; McDonald A; Wand H; Wroth S; Shuttleworth G; Keller AJ; Pink J; Wilson DP
    Transfusion; 2014 Jul; 54(7):1739-49. PubMed ID: 24720444
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Factors influencing confidential unit exclusions in blood donors.
    Sümnig A; Konerding U; Kohlmann T; Greinacher A
    Vox Sang; 2010 Apr; 98(3 Pt 1):e231-40. PubMed ID: 19765268
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Positive serology for viral hepatitis and donor self-exclusion in Southern Brazil.
    Maccarini Jde L; Nazario CA; Ferreira Jdos S; Ceglio WQ; Serpa RC; Ferreira VL; Lucca Schiavon Ld; Narciso-Schiavon JL
    Rev Soc Bras Med Trop; 2013; 46(4):403-10. PubMed ID: 23982095
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of blood donor deferral causes in the Trinidad and Tobago National Blood Transfusion Service.
    Charles KS; Hughes P; Gadd R; Bodkyn CJ; Rodriguez M
    Transfus Med; 2010 Feb; 20(1):11-4. PubMed ID: 19788640
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Donor deferral and resulting donor loss at the American Red Cross Blood Services, 2001 through 2006.
    Zou S; Musavi F; Notari EP; Rios JA; Trouern-Trend J; Fang CT
    Transfusion; 2008 Dec; 48(12):2531-9. PubMed ID: 18717777
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Successful exclusion of blood-borne viral disease in blood donors.
    Ramezani H; Bozorgi SH; Nooranipour M; Sadri M; Molaverdikhani S; Alavian SM
    Eur J Intern Med; 2011 Dec; 22(6):e71-4. PubMed ID: 22075316
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is there a risk of transfusion-transmissible infections after percutaneous needle treatments in blood donors? A systematic review and meta-analysis.
    Van Remoortel H; Moorkens D; Avau B; Compernolle V; Vandekerckhove P; De Buck E
    Vox Sang; 2019 May; 114(4):297-309. PubMed ID: 30972765
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Deferral patterns of voluntary blood donors at the National Blood Transfusion Service, North East Zonal Centre, Maiduguri.
    Kagu MB; Ahmed SG; Bashir MA; Malah MB; Usoro A; Gimba I; Babakura Y; Elisha J
    Afr J Med Med Sci; 2010 Jun; 39(2):119-25. PubMed ID: 21117408
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rates and reasons for blood donor deferral, Shiraz, Iran. A retrospective study.
    Kasraian L; Negarestani N
    Sao Paulo Med J; 2015 Feb; 133(1):36-42. PubMed ID: 25166463
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.